Aldehyde Dehydrogenase 2 Ameliorates Acute Cardiac Toxicity of Ethanol Role of Protein Phosphatase and Forkhead Transcription Factor by Ma, Heng et al.
A
a
c
m
w
b
(
i
m
e
F
U
t
b
F
2
Journal of the American College of Cardiology Vol. 54, No. 23, 2009
© 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00
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Aldehyde Dehydrogenase 2
Ameliorates Acute Cardiac Toxicity of Ethanol
Role of Protein Phosphatase and Forkhead Transcription Factor
Heng Ma, MD, PHD,*‡ Ji Li, PHD,‡ Feng Gao, MD, PHD,*† Jun Ren, MD, PHD*†‡
Xi’an, China; and Laramie, Wyoming
Objectives This study was designed to evaluate the role of facilitated detoxification of acetaldehyde, the main metabolic
product of ethanol, through systemic overexpression of mitochondrial aldehyde dehydrogenase-2 (ALDH2) on
acute ethanol exposure-induced myocardial damage.
Background Binge drinking may exert cardiac toxicity and interfere with heart function, manifested as impaired ventricular
contractility, although the underlying mechanism remains poorly defined.
Methods ALDH2 transgenic mice were produced using the chicken beta-actin promoter. Wild-type FVB (friend virus B) and
ALDH2 mice were challenged with ethanol (3 g/kg, intraperitoneally), and cardiac function was assessed 24 h
later using the Langendroff and cardiomyocyte edge-detection systems. Western blot analysis was used to evalu-
ate protein phosphatase 2A and 2C (PP2A and PP2C), phosphorylation of Akt, AMP-activated protein kinase
(AMPK), and the transcription factors Foxo3 (Thr32 and Ser413).
Results ALDH2 reduced ethanol-induced elevation in cardiac acetaldehyde levels. Acute ethanol challenge deteriorated
myocardial and cardiomyocyte contractile function evidenced by reduction in maximal velocity of pressure devel-
opment and decline (dP/dt), left ventricular developed pressure, cell shortening, and prolonged relengthening
duration, the effects of which were alleviated by ALDH2. Ethanol treatment dampened phosphorylation of Akt
and AMPK associated with up-regulated PP2A and PP2C, which was abrogated by ALDH2. ALDH2 significantly
attenuated ethanol-induced decrease in Akt- and AMPK-stimulated phosphorylation of Foxo3 at Thr32 and
Ser413, respectively. Consistently, ALDH2 rescued ethanol-induced myocardial apoptosis, protein damage, and
mitochondrial membrane potential depolarization.
Conclusions Our results suggest that ALDH2 is cardioprotective against acute ethanol toxicity, possibly through inhibi-
tion of protein phosphatases, leading to enhanced Akt and AMPK activation, and subsequently, inhibition of
Foxo3, apoptosis, and mitochondrial dysfunction. (J Am Coll Cardiol 2009;54:2187–96) © 2009 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.04.100A
p
a
e
r
a
t
t
c
(
p
I
tlcoholism, a worldwide major health problem, affects
pproximately 10% of the adult population in the U.S. In
ontrast to the cardioprotective benefits of light-to-
oderate alcohol consumption (up to 1 drink daily for
omen and 1 or 2 drinks daily for men), incidental heavy or
inge drinking increases cardiovascular events and mortality
1). Similar to chronic alcohol intake, frequent binge drink-
ng may predispose hearts to myopathic changes, including
yofibrillar disruption and reduced ventricular contractility
n route to the onset of alcoholic cardiomyopathy (2).
rom the *Department of Physiology and †Xijing Hospital, Fourth Military Medical
niversity, Xi’an, China; and the ‡Center for Cardiovascular Research and Alterna-
ive Medicine, University of Wyoming, Laramie, Wyoming. This work was supported
y NIAAA 1R01 AA013412, NCRR P20RR016474, and the National Science
oundation of China (#30728023).c
Manuscript received October 28, 2008; revised manuscript received March 10,
009, accepted April 2, 2009.lthough several hypotheses have been proposed for myo-
athic alterations following alcohol exposure including eth-
nol toxicity, reactive oxygen species, and fatty acid ethyl
ster accumulation (3,4), the ultimate culprit factor(s) still
emain unclear. As the first metabolic product of ethanol,
cetaldehyde is thought to mediate ethanol-induced cardiac
oxicity (3). Evidence from our lab and others has shown
See page 2197
hat acetaldehyde interrupts cardiac excitation–contraction
oupling and sarcoplasmic reticulum (SR) Ca2 release
3,5). Acetaldehyde is capable of reacting with functional
roteins to form protein adducts leading to tissue injury (6).
n general, aldehydes may increase the myocardial suscep-
ibility to ischemia reperfusion injury and mitigate certain
ardioprotective mechanisms such as nitric oxide (7). The
t
o
s
e
l
a
o
o
s
a
d
A
p
o
F
i
(
s
t
M
E
b
w
t
o
p
(
U
e
A
fi
i
c
c
p
t
t
A
t
g
c
s
fi
i
e
m
p
w
d
i
F
r
w
A
e
e
(
a
s
o
t
f
o
v
t
5
P
5
C
E
C
a
3
m
c
s
a
s
A
w
p
c
2188 Ma et al. JACC Vol. 54, No. 23, 2009
ALDH2 and Acute Cardiac Toxicity of Ethanol December 1, 2009:2187–96“acetaldehyde toxicity” theory re-
ceived some convincing support
from our recent observation that
overexpression of alcohol dehydro-
genase (ADH), which metabolizes
ethanol to acetaldehyde, accentu-
ated alcohol-induced myocardial
injury (8). Further evidence from
our lab indicated a protective
role of the mitochondrial isoform
of aldehyde dehydrogenase
(ALDH), ALDH2, in acetalde-
hyde or alcohol-induced tissue
injury (9). Consistent with these
observations, ALDH2 was re-
cently shown to reduce ischemic
injury to the heart (10), suggest-
ing its cardioprotective role.
Nonetheless, the mechanism
behind ALDH2-mediated pro-
tection and whether it relates to
the ALDH2-engaged break-
down of acetaldehyde remain
unknown. To test our hypoth-
esis that ALDH2 offers protec-
ion against acute ethanol toxicity through detoxification
f acetaldehyde, a transgenic mouse line with overexpres-
ion of human ALDH2 was produced to examine acute
thanol exposure-elicited cardiac toxicity and the under-
ying mechanisms, with a special focus on AMP-
ctivated protein kinase (AMPK) and Akt, key regulators
f survival and metabolism (11,12). Given that a member
f Forkhead transcription factors family (Foxo3) may
erve as a suitable candidate at the convergence of AMPK
nd Akt signaling (13), the phosphorylation of Foxo3 at
ifferent phosphorylation sites was further evaluated.
ctivation of Foxo3 at Ser413 by AMPK appears to
romotes stress resistance and longevity (14). On the
ther hand, Foxo3 activation at Thr32 by Akt shuts down
oxo3 transcriptional activity, favoring antiapoptosis,
mproved mitochondrial function, and insulin sensitivity
15). Therefore, the convergence of AMPK and Akt
ignaling at the level of Foxo3 may play a critical role in
he regulation of myocardial function.
ethods
xperimental animals, acute ethanol challenge, assay for
lood ethanol, and acetaldehyde. All animal procedures
ere approved by the University of Wyoming Institu-
ional Animal Care and Use Committee (Laramie, Wy-
ming). The human ALDH2 gene was amplified by
olymerase chain reaction from pT7-7-hpALDH2
kindly provided by Dr. Henry Weiner from Purdue
Abbreviations
and Acronyms
dL/dt  maximal velocity
of shortening/relengthening
dP/dt  maximal velocity
of pressure development
and decline
ADH  alcohol
dehydrogenase
ALDH  aldehyde
dehydrogenase
AMPK  AMP-activated
protein kinase
LVDP  left ventricular
developed pressure
PS  peak shortening
SR  sarcoplasmic
reticulum
TPS  time-to-90% peak
shortening
TR90  time-to-90%
relengthening
m  mitochondrial
membrane potentialniversity, Lafayette, Indiana) using the following prim- mrs: ALDH-F (5=-tcgaattctatgttgcgcgctgccgcccg) and
LDH-R (3=-cacggagtcttcttgagtattcttaaggc). The ampli-
ed ALDH2 fragment was digested with EcoRI and cloned
nto the EcoRI site of vector pBsCAG-2 under the CAG
assette, where ALDH activity was increased using the
hicken beta-actin promoter (9). The full length of the
romoter portion of the CAG-ALDH gene was sequenced
o confirm accuracy. The transgene can be removed from
he plasmid by digestion with KpnI and BamHI. The
LDH2 insert (Fig. 1A) was excised and separated from
he plasmid by KpnI/SstI restriction digestion and agarose
el electrophoresis. The insert was purified on Qiagen 20
olumns (QIAGEN Inc., Valencia, California), followed by
pin gel chromatography and filtration through 0.22-m
lters. A concentration of 1 g/l of the purified transgene
nsert deoxyribonucleic acid was microinjected into a 1-cell
mbryo of the inbred strain FVB. Around 20 to 30
icroinjected embryos were implanted into each pseudo-
regnant female and allowed to come to term. After
eaning, mouse tail clips were collected for genotyping of
eoxyribonucleic acid insertion of ALDH2. Further breed-
ng was conducted with the same background wild-type
VB. All mice were housed in a temperature-controlled
oom under a 12-h/12-h light/dark cycle with access to tap
ater ad libitum. Four-month-old adult male FVB and
LDH2 (F8) mice were selected for study. For acute
thanol challenge, mice were injected intraperitoneally with
thanol (3 g/kg) and were sacrificed under anesthesia
ketamine/xylazine: 3:1, 1.32 mg/kg, intraperitoneal) 24 h
fter ethanol injection.
Blood and hearts were collected in sealed vials and were
tored at 80°C until analysis. For analysis, a 2-ml aliquot
f the headspace gas from each vial was removed through
he septum on the cap with a gas-tight syringe and trans-
erred to a 200-l loop injection system. A volume of 100 l
f plasma from each sample was put into an autosampler
ial. Six microliters of n-propanol and 194 l of H2O were
hen added to the vial. Following a 20-min incubation at
0oC, a 50-l aliquot of headspace gas was removed.
lasma and heart samples transferred to a Hewlett-Packard
890 gas chromatograph (Hewlett-Packard, Palo Alto,
alifornia) equipped with a flame ionization detector.
thanol and acetaldehyde were separated on a 9-m VO-
OL capillary column with film of 1.8-m thickness and
n inner diameter of 0.32 mm. The temperature was held at
0°C, and the carrier gas was helium at a flow rate of 1.8
l/min. Quantitation was achieved by calibrating the gas
hromatograph peak areas against those from headspace
amples of known ethanol and acetaldehyde standards, over
similar concentration range as the tissue samples in the
ame buffer (16).
LDH2 enzymatic activity. ALDH2 enzymatic activity
as measured at 25°C in 33 mmol/l sodium pyrophos-
hate containing 0.8 mmol/l nicotinamide adenine dinu-
leotide (NAD), 15 mol/l propionaldehyde, and 0.1
l of cellular extract (50 g of protein). Propionalde-
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December 1, 2009:2187–96 ALDH2 and Acute Cardiac Toxicity of Ethanolyde, the substrate of ALDH2, was oxidized in propionic
cid by ALDH2, whereas NAD was reduced to reduced
orm of nicotinamide-adenine dinucleotide (NADH) to
uantitate the ALDH2 activity. Production of NADH
as determined by spectrophotometric absorbance at 340
m. ALDH2 activity was expressed as nanomoles
ADH/minute per milligram protein. An extinction
oefficient of 6.22/mmol per cm for NADH was used for
he calculation of reaction rates (17).
rotein carbonyl formation. Protein was precipitated by
dding an equal volume of 20% trichloroacetic acid and
entrifuged for 1 min. The sample was resuspended in 10
mol/l 2,4-dinitrophenylhydrazine (2,4-DNPH) solution
or 15 to 30 min at room temperature before 20% trichlo-
oacetic acid was added and samples were centrifuged for
min. The precipitate was resuspended in 6 mol/l guani-
ine solution. The maximum absorbance (360 to 390 nm)
as read against appropriate blanks (2 mol/l HCl), and the
arbonyl content was calculated using the formula: absorp-
ion at 360 nm  45.45 nmol/protein content (mg) (16).
ouse heart perfusion. Mouse hearts were retrogradely
erfused with a Krebs-Henseleit buffer containing 7 mmol/l
lucose, 0.4 mmol/l oleate, 1% BSA, and a low fasting
oncentration of insulin (10 U/ml). Hearts were perfused
t a constant flow of 4 ml/min (equal to an aortic pressure
f 80 cm H2O) at baseline for 60 min. A fluid-filled latex
alloon connected to a solid-state pressure transducer was
nserted into the left ventricle through a left atriotomy to
Figure 1 ALDH2 Transgene
(A) Scheme of the ALDH2 transgene construct. The black boxes depict chicken b
deoxyribonucleic acid. The cross-hatched box contains the polyadenylation site of
parentheses were destroyed in construction. (B) ALDH2 expression and (C) ALDH
Mean  SEM, n  3, *p  0.05 versus FVB group, #p  0.05 versus FVBEtOHeasure pressure. Left ventricular developed pressure dLVDP), maximal velocity of pressure development and
ecline (dP/dt), and heart rate were recorded using a
igital acquisition system at a balloon volume that resulted
n a baseline LV end-diastolic pressure of 5 mm Hg (18).
ardiomyocyte isolation. After ketamine/xylazine seda-
ion, hearts were removed and perfused with Krebs-
enseleit buffer containing (in mmol/l): 118 NaCl, 4.7
Cl, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 10 hydroxy-
thnyl piperazine ethanesulfonic acid (HEPES), and 11.1
lucose. Hearts were digested with 223 U/ml collagenase D
or 20 min. Left ventricles were removed and minced before
eing filtered. Myocyte yield was 75%, which was not
ffected by either acute ethanol challenge or ALDH2
ransgene. Only rod-shaped myocytes with clear edges were
elected for mechanical study (16).
ell shortening and relengthening. Mechanical proper-
ies of cardiomyocytes were evaluated utilizing a SoftEdge
yoCam system (IonOptix Corporation, Milton, Massa-
husetts) (16). Briefly, cardiomyocytes were visualized under
n inverted microscope (Olympus, IX-70, Olympus Optical
o., Tokyo, Japan) and were stimulated with a voltage
requency of 0.5 Hz. The myocyte being observed was
hown on a computer monitor using an IonOptix MyoCam
amera. IonOptix SoftEdge software was utilized to capture
ell shortening and relengthening changes. The indexes
onsidered were peak shortening amplitude (PS), time-to-
eak shortening (TPS), time-to-90% relengthening (TR90),
nd maximal velocity of shortening/relengthening (dL/
in promoter. The open box contains the full-length human ALDH2 complementary
ulin II gene. Some restriction sites used in construction are shown. Sites in
ity from FVB and ALDH2 mice with or without acute ethanol (EtOH) challenge.
. ALDH  aldehyde dehydrogenase.eta-act
rat ins
2 activ
groupt). In the case of stimulus alternation from 0.1 to 5.0 Hz,
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ALDH2 and Acute Cardiac Toxicity of Ethanol December 1, 2009:2187–96he steady-state contraction of myocytes was achieved (usu-
lly after the first 5 to 6 beats) before PS was recorded.
estern blot. Ventricular tissues were homogenized and
onicated in a lysis buffer containing 20 mmol/l Tris (pH
.4), 150 mmol/l NaCl, 1 mmol/l ethylenediaminetetraace-
ic acid (EDTA), 1 mmol/l ethyleneglycoltetraacetic acid
EGTA), 1% Triton, 0.1% SDS, and 1% protease inhibitor
ocktail. Equal amounts (30 g) of proteins were separated
n 10% or 15% SDS-polyacrylamide gels in a minigel
pparatus (Mini-PROTEAN II, Bio-Rad Laboratories
nc., Hercules, California) and were then transferred elec-
rophoretically to nitrocellulose membranes. The mem-
ranes were blocked with 5% milk in Tris-buffered saline
efore overnight incubation at 4°C with anti-ALDH2
1:1,000), anti-Akt (1:1,000), anti-pAkt (Thr308, 1:1,000),
nti-AMPK (1:1,000), anti-pAMPK (Thr172, 1:1,000),
nti-Foxo3 (1:1,000), anti-pFoxo3 (Ser413, Thr32,
:1,000), anti-PP2C (1:1,000), and anti-PP2A (1:1,000)
ntibodies. Membranes were then incubated for 1 h with
orseradish peroxidase (HRP)-conjugated secondary antibody
1:5,000). After immunoblotting, films were scanned and the
ntensity of immunoblot bands was detected with a Bio-Rad
alibrated Densitometer (8).
aspase-3 assay. Caspase-3 is an enzyme activated during
nduction of apoptosis. Caspase-3 activity was determined
ccording to published method (9). In brief, myocytes were
ysed in 100 l of ice-cold cell lysis buffer (50 mmol/l
EPES, 0.1% 3-[(3-cholamidopropyl)dimethylammonio]-
-propanesulfonate (CHAPS), 1 mmol/l dithiothreitol, 0.1
mol/l EDTA, 0.1% NP40). Following cell lysis, 70 l of
eaction buffer and 20 l of caspase-3 colorimetric substrate
Ac-DEVD-p-nitroanilide) were added to cell lysate and
ncubated for 1 h at 37°C, during which time, caspase
nzyme in the sample was allowed to cleave the chro-
General Features of FVB and ALDH2 Mice WithTable 1 General Features of FVB and ALDH2
F
Body weight (g) 25.1
Heart weight (mg) 157
Heart/weight (mg/g) 6.24
Liver weight (g) 1.46
Liver/body weight (mg/g) 57.8
Kidney weight (mg) 402
Kidney/body weight (mg/g) 16.0
Cardiac acetaldehyde (nmol/mg) 4.93
Blood alcohol (mol/l) 1 h Unde
Blood alcohol (mol/l) 6 h Unde
Cardiac protein carbonyl levels (nmol/mg protein) 1.20
Heart rate (ex vivo, beats/min) 289
LVDP (mm Hg) 77.9
dP/dt (mm Hg/s) 3,745
dP/dt (mm Hg/s) 2,226
Mean  SEM, n  10 mice per group, *p  0.05 versus FVB group, †
EtOH ethanol; LVDP left ventricular developed pressure; dp/dtmaxim
of pressure development and decline.ophore pNA from its substrate molecule. Absorbency was
etected at 405 nm, with caspase-3 activity being propor-
ional to the color reaction. Caspase-3 activity was expressed
s picomoles of p-nitroanilide released per micrograms of
rotein per minute.
easurement of mitochondrial membrane potential
m). Cardiomyocytes were suspended in HEPES-
aline buffer, and 	m was detected as described (19).
riefly, following a 10-min pre-incubation with 5 mol/l
C-1 at 37°C, cells were rinsed twice using the HS buffer
ree of JC-1. Fluorescence of each sample was read at
xcitation wavelength of 490 nm and emission wavelength
f 530 and 590 nm using a spectrofluorimeter (Spectra
axGeminiXS, Spectra Max, Atlanta, Georgia) at an
nterval of 10 s. Results in fluorescence intensity were expressed
s the 590- to 530-nm emission ratio. The mitochondrial
ncoupler carbonyl cyanide m-chlorophenylhydrazone
CCCP, 10 mol/l) was used as a positive control for 	m
easurement.
tatistical analysis. Data were expressed as mean  stan-
ard error of the mean (SEM). Statistical significance (p 
.05) for each variable was estimated by analysis of variance
ollowed by Tukey’s test for post-hoc analysis.
esults
eneral features and whole-heart function of FVB and
LDH2 mice. ALDH2 transgene itself did not affect body
nd organ weights. Acute ethanol injection elicited compa-
able elevation in blood alcohol levels and cardiac acetalde-
yde levels, which were minimal in nonethanol-treated
ice, without affecting body and organ weights. Although
lood alcohol levels were equally elevated in both FVB and
LDH2 mice at 1 or 6 h following ethanol injection, cardiac
ithout Acute Ethanol Challengee With or Without Acute Ethanol Challenge
Mouse Group
FVBEtOH ALDH2 ALDH2EtOH
25.7 1.0 25.3 1.0 25.7 0.9
163 13 166 12 172 10
9 6.29 0.32 6.53 0.28 6.65 0.38
4 1.58 0.10 1.47 0.13 1.60 0.10
61.4 1.6 58.4 4.8 62.2 1.5
424 18 421 23 418 9
16.5 0.3 16.6 0.4 16.3 0.3
6 48.813.83* 4.83 0.23 18.4 1.26*†
le 105 12* Undetectable 112 15*
le 4.83 2.31* Undetectable 5.27 1.56*
7 2.41 0.24* 1.16 0.13 1.65 0.28*†
294 15 301 13 281 14
31.2 3.3* 76.4 2.6 54.3 4.8*†
4 981 88* 3,674 186 2,858 169*†
1,009 44* 2,280 131 1,720 158*†
5 versus FVBEtOH group.or WMic
VB
 0.7
 10
 0.2
 0.1
 4.3
 15
 0.3
 0.4
tectab
tectab
 0.1
 12
 2.1
 15
 89
p  0.0
al velocity of shortening/relengthening;dP/dtmaximal velocity
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December 1, 2009:2187–96 ALDH2 and Acute Cardiac Toxicity of Ethanolcetaldehyde levels were significantly lower in ALDH2 mice
ollowing ethanol challenge, validating this transgenic model of
acilitated acetaldehyde detoxification. Protein carbonyl forma-
ion, an indicator of protein oxidation and protein damage, was
ignificantly elevated in response to acute ethanol challenge,
he effect of which was partially inhibited by the ALDH2
ransgene. Assessment of whole-heart function including
VDP and maximal velocity of pressure development and
ecline (dP/dt) revealed a significant decline in response to
cute ethanol challenge, the effect of which was attenuated by
LDH2. No difference was noted in ex vivo heart rate among
ll mouse groups tested (Table 1). Transgenic overexpression
f ALDH2 significantly enhanced cardiac ALDH2 expres-
ion and its enzymatic activity. Acute ethanol treatment
ailed to alter ALDH2 protein expression although it
ignificantly promoted ALDH2 enzymatic activity equally
n both FVB and ALDH2 mice (Figs. 1B and 1C).
Figure 2 Cardiomyocyte Mechanical Properties
Effect of acute ethanol exposure on cell shortening in cardiomyocytes from FVB an
(C) maximal velocity of shortening (dL/dt); (D) maximal velocity of relengtheningffect of acute ethanol exposure on cardiomyocyte me-
hanics in FVB and ALDH2 mice. Our further assess-
ent of cardiomyocyte mechanics revealed that acute
thanol treatment significantly depressed peak shortening
nd dL/dt as well as prolonged TR90 without affecting
PS. Although the ALDH2 transgene itself did not
ffect these mechanical indexes, it significantly attenuated
cute ethanol exposure-induced cardiomyocyte mechan-
cal abnormalities (Fig. 2). To evaluate the potential
ontribution of SR in ethanol and/or ALDH2-elicited
ardiac contractile responses, cardiomyocytes from FVB
r ALDH2 mice treated with or without ethanol were
aced at higher stimulating frequencies to examine the
R Ca2 handling capacity. The cells were initially
timulated to contract at 0.5 Hz for 5 min to ensure a
teady state prior to raising the stimulating frequency to
.0 Hz. Figure 3 exhibits a comparable negative staircase
H2 mice. (A) resting cell length (CL); (B) peak cell shortening (normalized to CL);
dt); (E) time-to-peak shortening (TPS); and (F) time-to-90% relengthening (TR90).d ALD
(dL/
Mean  SEM, n  150 to 200 cells from 3 mice per group, *p  0.05 versus FVB group, #p  0.05 versus FVBEtOH group. Abbreviations as in Figure 1.
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ALDH2 and Acute Cardiac Toxicity of Ethanol December 1, 2009:2187–96n PS with increased stimulus frequency between FVB and
LDH2 mice in the absence of ethanol exposure. Acute
thanol exposure exaggerated high stimulus frequency-
licited depression in PS, the effect of which was signifi-
antly attenuated by ALDH2.
ffect of ALDH2 on ethanol-induced change in Akt,
MPK, and Foxo signaling. To examine the potential
ignaling pathways involved in ethanol and/or ALDH2-
licited cardiac mechanical response, we examined levels of
he key cardiac surviving factor Akt and the cardiac energy
uel AMPK. Our results indicated that acute ethanol
reatment markedly decreased phosphorylation of both Akt
nd AMPK in FVB mice, which was abrogated by
LDH2. These data suggest that ALDH2 may compensate
or the loss of activation in Akt and AMPK in response to
cute ethanol treatment. Consistently, our data further
evealed reduction of the Akt-engaged phosphorylation of
oxo3 at Thr32 and the AMPK-activated Foxo3 phosphor-
lation at Ser413 following ethanol treatment. ALDH2
estored acute ethanol exposure-depressed Foxo3 phosphor-
lation at both sites (Fig. 4). These results suggest involve-
ent of the Akt-Foxo3 (Thr32) and AMPK-Foxo3
Ser413) cascades in ethanol and/or ALDH2-induced car-
iac responses.
ffect of ALDH2 on ethanol-induced changes in protein
hosphatases. Recent evidence has indicated Akt is de-
hosphorylated by protein phosphatase 2A (PP2A),
hereas AMPK is dephosphorylated by protein phospha-
ase 2C (PP2C) (15,20,21). To examine the possible mech-
nisms behind ethanol-induced reduction in the phosphor-
lation of Akt and AMPK, expression of PP2A and PP2C
as evaluated in myocardium from FVB and ALDH2 mice
Figure 3 Frequency-Shortening Response in Cardiomyocytes
Frequency (0.1 to 5.0 Hz) response in peak shortening amplitude in cardiomyo-
cytes from FVB and ALDH2 mice with or without acute ethanol challenge. Peak
shortening is shown as percent change from its value obtained at 0.1 Hz of
the same cell. Mean  SEM, number of cells is given in parentheses. *p 
0.05 versus FVB group, #p  0.05 versus FVBEtOH group. Abbreviations as
in Figure 1.ith or without acute ethanol exposure. Our result shown in tigure 5 indicated that ethanol treatment significantly
p-regulated the levels of PP2A and PP2C in FVB but not
LDH2 mice, indicating a likely role of up-regulated PP2A
nd PP2C proteins in the ethanol-induced loss of phos-
horylation in Akt and AMPK, respectively.
ffect of ALDH2 on ethanol-induced cardiomyocyte
poptosis and mitochondrial damage. Apoptosis, a key
lement for a variety of pathological heart conditions,
ontributes to alcoholic heart injury (12). Our current data
uggested a possible role of Akt-Foxo3 (Thr32) and
MPK-Foxo3 (Ser413) pathways in ethanol- and/or
LDH2-elicited response. Considering the close tie among
kt, AMPK, and Foxo3 in cardiomyocyte survival and
unction (11,12,22), we further examined apoptosis in
yocardium following ethanol treatment. Results shown in
igure 6A revealed that caspase-3 activity was significantly
levated in cardiomyocytes following acute ethanol chal-
enge, the effect of which was significantly attenuated by
LDH2.
Given that mitochondrial function is essential to cardio-
yocyte viability and function (4,23), the cationic lipophilic
robe JC-1 was employed to monitor 	m in response to
cute ethanol treatment. The dynamic change of 	m was
isplayed by change in the ratio between red (aggregated
C-1) and green (monomeric form of JC-1) fluorescence.
uantitative analysis showed a significant reduction in the
atio between red and green fluorescence in response to a
0-min ethanol treatment, indicating a fall in 	m and
itochondrial damage. Interestingly, the ethanol-induced
all in 	m was abrogated by ALDH2. The ALDH2
ransgene itself did not exert any significant effect on 	m
Fig. 6B).
iscussion
ur study was designed based on the hypothesis that
cetaldehyde is the ultimate culprit toxin for ethanol-
nduced toxicity. To test this hypothesis, a transgenic mouse
ine was generated with systemic overexpression of ALDH2
o facilitate the detoxification of acetaldehyde. Our major
ndings revealed that ALDH2 reduced cardiac acetalde-
yde levels and lessened acute ethanol-induced myocardial
ontractile dysfunction, apoptosis, and protein damage. Our
ata further indicated that ALDH2 reconciled the acute
thanol-induced dephosphorylation of Akt and AMPK
ossibly associated with an up-regulation of protein phos-
hatases (PP2A and PP2C). Meanwhile, our study revealed
cross-talk between Akt and AMPK signaling pathways at
he converging point of Foxo3, leading to inactivation
phosphorylation) of Forkhead transcriptional factors and
nhibition of myocardial apoptosis, protein, and mitochon-
rial damage in the ethanol-treated ALDH2 mice. Taken
ogether, this study demonstrated that ALDH2 may be
rotective against acute ethanol-induced cardiac toxicity
hrough inhibition of protein phosphatases, preserved phos-
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poptosis, protein, and mitochondrial damage.
Low-to-moderate intake of alcohol is associated with a
etter health outcome than less frequent consumption.
inge drinking, even among otherwise light drinkers,
ontributes to cardiovascular events, myocardial abnor-
alities, and mortality (1,2). Ethanol-induced cardiac
amage is evident if acute alcohol consumption exceeds
0 to 100 g/day in humans (2), which can be transpired
o a dosage of 1.5 g/kg for an average adult weighing 70
g. Therefore, the dosage of ethanol used in our study
3 g/kg) closely resembles a state of heavy ethanol
onsumption, given that rodents are more resist than
umans to ethanol intoxication. The principal indicator
f myopathic alteration following ethanol exposure is
haracterized by compromised myocardial contractility
2,24). This is supported by results from our current
tudy in that acute ethanol exposure triggered deterio-
ated in heart contractile function, as evidenced by
educed dP/dt and LVDP, prolonged TR90, and de-
Figure 4 Ethanol-Induced Change in Akt, AMPK, and Foxo Sign
Acute ethanol exposure-induced change in phosphorylation of Akt (A), Foxo3 (Thr 3
genic mice. (Top images of each panel) Representative gel blots of total and pho
 0.05 versus FVB group, #p  0.05 versus FVBEtOH group. Abbreviations as iressed cell shortening and dL/dt associated with sormal TPS. Not surprisingly, little geometric alteration
as observed in our acute setting of ethanol treatment.
everal rationales may be derived toward the acute
thanol exposure-induced cardiac toxicity may have mul-
iple causes, including lipid peroxidation, oxidative dam-
ge (3), acetaldehyde oxidation (5), and altered mem-
rane properties (25). Among which, acetaldehyde may
e the top candidate for the rapid onset of cardiac toxicity
esponsible for overt myocardial injury within 24 h. As
he major metabolite of ethanol, acetaldehyde is capable
f generating free radicals via aldehyde oxidase and/or
anthine oxidase-associated oxidation (26). In our earlier
tudy, we reported greater levels of lipid peroxidation and
rotein carbonyls associated with dampened intercellular
a2 release and SR Ca2 load in myocardium from
ardiac-specific ADH transgenic mice (16). More re-
ently, we demonstrated that elevated cardiac acetalde-
yde exposure via ADH overexpression exacerbates
lcohol-induced myocardial dysfunction, hypertrophy,
nsulin insensitivity, and endoplasmic reticulum (ER)
), AMPK (C), and Foxo3 (Ser 413) (D) in myocardium from FVB and ALDH2 trans-
lated proteins using specific antibodies. Mean  SEM, n  5 mice per group. *p
e 1.aling
2) (B
sphory
n Figurtress (8). Although our previous studies demonstrated
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ALDH2 and Acute Cardiac Toxicity of Ethanol December 1, 2009:2187–96verexpression of ALDH2 in cell culture alleviates
cetaldehyde-induced cell injury in human umbilical vein
ndothelial cells and human cardiac cells (9,17), little
nowledge is available with regards to the effect of
LDH2 on acute ethanol toxicity on the hearts. Data
rom our current study revealed for the first time, to our
nowledge, that ALDH2 counteracts cardiac acetalde-
yde exposure and protects myocardial function against
cute ethanol toxicity. These results have convincingly
alidated the notion that acetaldehyde may be a critical
layer in acute ethanol toxicity in the hearts, favoring a
ardioprotective role of ALDH2. Pharmacological eleva-
ion of ALDH2 activity was previously shown to reduce
he ischemic heart damage (10). Interestingly, our data
evealed overtly elevated ALDH activity in response to
cute ethanol challenge, representing the likelihood of a
ompensatory protective response against harmful insults.
In hearts, both AMPK and Akt are deemed key regula-
ors of myocardial function (11,12). Nonetheless, possible
ross-talk between the 2 under physiological or pathophys-
ological state is still unclear. Our earlier study indicated that
lcohol intake-induced cardiomyocyte contractile dysfunc-
ion is associated with a reduced Akt activity (27), although
ittle is known for AMPK. Data from our current study
evealed dampened phosphorylation of both Akt and
MPK in conjunction with compromised cardiac function
n response to acute ethanol treatment. Akt and AMPK are
oth essential for cardiac survival and energy fuel, as well as
ontractile function (11,12,27). Our observation that
LDH2 compensates for the loss of activation in Akt and
MPK in response to ethanol treatment suggests a possible
ole of these signaling molecules in the ALDH2-induced
ardioprotection against acute ethanol toxicity. It was re-
m FVB and ALDH2 transgenic mice. (Top panels) Representative gel blots
ean  SEM, n  5 mice per group, *p  0.05 versus FVB group, #p  0.05Figure 5 Ethanol-Induced Changes in Protein Phosphatases
Acute ethanol exposure-induced change in PP2A (A) and PP2C (B) in myocardium fro
depicting PP2A, PP2C, and the loading control beta-actin using specific antibodies. M
versus FVBEtOH group. Abbreviations as in Figure 1.Figure 6 Ethanol-Induced Apoptosis
and Mitochondrial Damage
Effect of ALDH2 transgene on acute ethanol exposure-induced apoptosis evalu-
ated using caspase-3 activity (A) and cardiomyocyte mitochondrial membrane
potential (B). Mean  SEM, n  5 mice per group. *p  0.05 versus FVB
group, #p  0.05 versus FVBEtOH group. Abbreviations as in Figure 1.ently shown that Akt and AMPK are dephosphorylated by
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December 1, 2009:2187–96 ALDH2 and Acute Cardiac Toxicity of EthanolP2A (15,20) and PP2C (28), respectively. Our current
tudy detected significantly up-regulated PP2A and PP2C
roteins in FVB mice following acute ethanol treatment,
uggesting a role of PP2A and PP2C in the reduced
hosphorylation of Akt and AMPK, respectively. The
bility of ALDH2 to alleviate the acute ethanol exposure-
nduced elevation in these 2 protein phosphatases provides
urther evidence for the regulation of PP2A and PP2C in
kt and AMPK signaling, respectively, under our current
xperimental setting.
Foxo3 has been considered a converging point for Akt
nd AMPK signaling pathways (13). AMPK phosphoryla-
ion of Foxo3 at the site of Ser413 enhances the stress
esistance and longevity (13,14). On the other hand, Akt
hosphorylation of Foxo3 at Thr32 inhibits Foxo3 tran-
criptional activity, promoting antiapoptosis and insulin
ensitivity (15). Therefore, Akt and AMPK signaling may
licit transcriptional regulation via Foxo3 to allow organis-
al adaptation to physiological or pathophysiological
hanges. The convergence of the 2 pathways at the level of
oxo3 may play a critical role for the cross-talk between Akt
nd AMPK. In the present study, acute ethanol exposure-
nduced loss of phosphorylation of Akt and AMPK was
estored in ALDH2 mice. These data favor Foxo3 as a
onverging point between Akt and AMPK pathways fol-
owing ethanol exposure. The ALDH2 enzyme-induced
rotection on both Akt-Foxo3 (Thr32) and AMPK-Foxo3
Ser413) pathways is likely a secondary effect of facilitated
etoxification of acetaldehyde following ethanol exposure.
oxo transcriptional factors are known regulators for cell
ycle and apoptosis, especially for Akt and AMPK-
ediated antiapoptotic properties (22). Our data revealed
nhanced caspase-3 activity, carbonyl formation, and mito-
hondrial damage in FVB but not ALDH2 mice following
cute ethanol challenge. These data suggest a possible role
f Akt-Foxo and AMPK-Foxo in the ethanol-induced
poptosis and mitochondrial dysfunction as well as the
eneficial role of ALDH2. However, given the nature of
ssociate rather than causal relationship of our data in cell
ignaling and cell injury, further study is warranted to better
lucidate the role of Akt, AMPK, and Foxo3 in ALDH2-
licited cardioprotection against ethanol toxicity.
onclusions
he present study has provided convincing evidence that
LDH2 attenuated acute ethanol exposure-induced myo-
ardial dysfunction, apoptosis, and protein and mitochon-
rial damage, possibly through inhibition of protein phos-
hatases, leading to preserved phosphorylation of Akt and
MPK on Foxo3. Further study is warranted to unveil the
mpact of ALDH2 on the more clinically relevant condition
f chronic alcohol ingestion-induced onset and progression
f alcoholic cardiomyopathy.cknowledgment
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